Top Ten Common Prejudices About Polyethylene Naphthalate Market.
The majority of medical procedures use intravenous (IV) treatment products. These supplies make it possible to provide numerous nutrients and drugs directly into a patient's bloodstream in a simple and safe manner. IV treatment is simple to use and usually only requires one needle poke. Patients will be more comfortable and have a better overall experience as a result of this. Nutrients, pain relievers, chemotherapeutic medications, and antibiotics are all popular treatments. The main benefit of a disposable IV treatment product is the exact and regulated administration of drug dosage throughout the body.
Over the forecast period, an increase in the number of chronic diseases requiring disposable IV therapy products is likely to be a prominent factor driving the global disposable IV therapy products market. Chronic diseases were the leading cause of mortality in 2014, according to the Centers for Disease Control and Prevention (CDC). Cancer and heart disease were responsible for almost 46% of all deaths. In adults, diabetes is the leading cause of renal failure, lower-limb amputations, and new cases of vision impairment.
An growth in the number of chronic diseases requiring disposable IV therapy products is expected to be a major driver driving the worldwide disposable IV therapy products market throughout the forecast period. According to the Centers for Disease Control and Prevention, chronic diseases were the top cause of death in 2014. (CDC). Cancer and heart disease were the leading causes of death, accounting for over 46% of all deaths. Diabetic kidney failure, lower-limb amputations, and new occurrences of vision impairment are all common in adults with diabetes.
The effective and safe use of IV therapies has been enabled by a growing focus on cost containment and cost effectiveness at health care facilities, as well as technological developments in IV therapy products. Over the projected period, the disposable IV treatment products market is expected to rise due to patients' growing preference for safety-enhancing pumping tools and needleless technologies.
For example, CareFusion (a Becton Dickinson company) introduced the MaxZero needleless connector (zero reflux connector) in 2014, which uses the same technology as the MaxPlus connector to lower the risk of occlusions and infections. Product recalls, reported faults, and a scarcity of skilled personnel are projected to stymie the market for disposable IV treatment devices over the projection period. For example, when a major problem arises, such as an obstruction or the presence of air in the infusion tube, the infusion pump fails to sound an audible alarm.
B. Braun Melsungen AG, Baxter, Becton Dickinson & Company, Caesarea Medical Electronics, ICU Medical, Inc., JMS Co. Ltd., Lily Medical Corporation, Smiths Medical, and Terumo Corporation are among the main competitors in the worldwide disposable IV treatment products market.
Comments
Post a Comment